3D Pharmacophore models are three-dimensional ensembles of chemically specified interactions of a ligand in its bioactive state. They are now an important technique in drug design because they offer a sophisticated method of deciphering chemically stored ligand information. The important research for using 3D pharmacophore models in high - throughput screening and mechanistic investigations for protein functioning are summarised in this review, along with an outline of the method's fundamental principles. We also go over current advancements in the area. Since these methods take into account macromolecule-ligand interactions as dynamic and hence display an interaction pattern that is physiologically accurate, combining 3D pharmacophore models with molecular dynamics simulations might be a huge step forward. The effective use of 3D pharmacophore data in artificial intelligence and machine learning is another trend. Other themes include using 3D pharmacophore data effectively in machine learning and artificial intelligence applications or providing 3D pharmacophore modelling on publicly available web servers. Recent advancements demonstrate that 3D pharmacophore modelling is a dynamic area with many implications in drug discovery and beyond.
Submit your abstract Today
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India
Title : Bridging tradition and innovation: Inorganic meets green synthesis
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy